Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bot

Accord Healthcare, Inc. has issued a Class II recall for Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in 90-count and 1000-count bottles (NDC 16729-451-15 and 16729-451-17). The product, manufactured by Intas Pharmaceuticals Limited in India, was recalled due to subpotency, according to the recall notice.

Most relevant for: Patients taking levothyroxine 100 mcg tablets from this manufacturer and lot who may not be receiving adequate thyroid hormone replacement due to subpotent medication

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.